FR2897775B1 - Biomateriau, implant injectable le comprenant, son procede de preparation et ses utilisations - Google Patents

Biomateriau, implant injectable le comprenant, son procede de preparation et ses utilisations

Info

Publication number
FR2897775B1
FR2897775B1 FR0601657A FR0601657A FR2897775B1 FR 2897775 B1 FR2897775 B1 FR 2897775B1 FR 0601657 A FR0601657 A FR 0601657A FR 0601657 A FR0601657 A FR 0601657A FR 2897775 B1 FR2897775 B1 FR 2897775B1
Authority
FR
France
Prior art keywords
biomateriau
preparing
same
injectable implant
injectable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0601657A
Other languages
English (en)
Other versions
FR2897775A1 (fr
Inventor
Elisabeth Laugier
Frank Gouchet
Bernard Grandmontagne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maruho Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0601657A priority Critical patent/FR2897775B1/fr
Application filed by Individual filed Critical Individual
Priority to EP07705634.9A priority patent/EP1986599B1/fr
Priority to ARP070100732A priority patent/AR059598A1/es
Priority to CN2007800061018A priority patent/CN101404977B/zh
Priority to CA2643783A priority patent/CA2643783C/fr
Priority to RU2008137983/15A priority patent/RU2008137983A/ru
Priority to BRPI0708157A priority patent/BRPI0708157B1/pt
Priority to PCT/IB2007/000422 priority patent/WO2007096748A2/fr
Priority to KR1020087023320A priority patent/KR101402832B1/ko
Priority to PL07705634T priority patent/PL1986599T3/pl
Priority to US11/677,389 priority patent/US9339590B2/en
Priority to JP2008555893A priority patent/JP5165596B2/ja
Priority to ES07705634.9T priority patent/ES2444850T3/es
Priority to MX2008010718A priority patent/MX2008010718A/es
Publication of FR2897775A1 publication Critical patent/FR2897775A1/fr
Priority to IL193540A priority patent/IL193540A/en
Application granted granted Critical
Publication of FR2897775B1 publication Critical patent/FR2897775B1/fr
Priority to US15/091,142 priority patent/US10086111B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Urology & Nephrology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0601657A 2006-02-24 2006-02-24 Biomateriau, implant injectable le comprenant, son procede de preparation et ses utilisations Expired - Fee Related FR2897775B1 (fr)

Priority Applications (16)

Application Number Priority Date Filing Date Title
FR0601657A FR2897775B1 (fr) 2006-02-24 2006-02-24 Biomateriau, implant injectable le comprenant, son procede de preparation et ses utilisations
US11/677,389 US9339590B2 (en) 2006-02-24 2007-02-21 Biomaterial, injectable implant comprising it, its method of preparation and its uses
CN2007800061018A CN101404977B (zh) 2006-02-24 2007-02-21 生物材料及其可注射植入物、制备方法以及用途
CA2643783A CA2643783C (fr) 2006-02-24 2007-02-21 Biomateriau, implant injectable comprenant celui-ci, procede de preparation de celui-ci et utilisation de celui-ci
RU2008137983/15A RU2008137983A (ru) 2006-02-24 2007-02-21 Биоматериал, включающий его имплантант, вводимый с помощью инъекции, способ его получения и его применение
BRPI0708157A BRPI0708157B1 (pt) 2006-02-24 2007-02-21 biomaterial e implante injetável do mesmo, método de preparação e uso
PCT/IB2007/000422 WO2007096748A2 (fr) 2006-02-24 2007-02-21 Biomatériau, implant injectable comprenant celui-ci, procédé de préparation de celui-ci et utilisation de celui-ci
KR1020087023320A KR101402832B1 (ko) 2006-02-24 2007-02-21 생체재료, 및 이를 포함하는 주입식 이식물질, 및 이의 제조방법 및 용도
EP07705634.9A EP1986599B1 (fr) 2006-02-24 2007-02-21 Biomatériau, implant injectable comprenant celui-ci, procédé de préparation de celui-ci et utilisation de celui-ci
ARP070100732A AR059598A1 (es) 2006-02-24 2007-02-21 Biomaterial, implante inyectable que lo comprende, su metodo de preparacion y sus usos
JP2008555893A JP5165596B2 (ja) 2006-02-24 2007-02-21 生体材料、それを含む注射可能なインプラント、その調製方法およびその使用
ES07705634.9T ES2444850T3 (es) 2006-02-24 2007-02-21 Biomaterial e implante inyectable que lo contiene, su método de preparación y su uso
MX2008010718A MX2008010718A (es) 2006-02-24 2007-02-21 Biomaterial, implante inyectable que lo comprende, su metodo de preparacion y sus usos.
PL07705634T PL1986599T3 (pl) 2006-02-24 2007-02-21 Biomateriał i implant go obejmujący nadający się do wstrzykiwania, sposób jego wytwarzania i zastosowanie
IL193540A IL193540A (en) 2006-02-24 2008-08-19 Biological material, an injectable implant containing it, a method of preparation and use
US15/091,142 US10086111B2 (en) 2006-02-24 2016-04-05 Biomaterial, injectable implant comprising it, its method of preparation and its uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0601657A FR2897775B1 (fr) 2006-02-24 2006-02-24 Biomateriau, implant injectable le comprenant, son procede de preparation et ses utilisations

Publications (2)

Publication Number Publication Date
FR2897775A1 FR2897775A1 (fr) 2007-08-31
FR2897775B1 true FR2897775B1 (fr) 2013-05-03

Family

ID=37227278

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0601657A Expired - Fee Related FR2897775B1 (fr) 2006-02-24 2006-02-24 Biomateriau, implant injectable le comprenant, son procede de preparation et ses utilisations

Country Status (15)

Country Link
US (2) US9339590B2 (fr)
EP (1) EP1986599B1 (fr)
JP (1) JP5165596B2 (fr)
KR (1) KR101402832B1 (fr)
CN (1) CN101404977B (fr)
AR (1) AR059598A1 (fr)
BR (1) BRPI0708157B1 (fr)
CA (1) CA2643783C (fr)
ES (1) ES2444850T3 (fr)
FR (1) FR2897775B1 (fr)
IL (1) IL193540A (fr)
MX (1) MX2008010718A (fr)
PL (1) PL1986599T3 (fr)
RU (1) RU2008137983A (fr)
WO (1) WO2007096748A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2897775B1 (fr) * 2006-02-24 2013-05-03 Elisabeth Laugier Biomateriau, implant injectable le comprenant, son procede de preparation et ses utilisations
US7776840B2 (en) * 2007-02-21 2010-08-17 Cutanea Life Sciences, Inc. Methods of use of biomaterial and injectable implant containing biomaterial
KR101610268B1 (ko) 2007-08-28 2016-04-07 애들레이드 리서치 앤드 이노베이션 피티와이 리미티드 외과용 하이드로겔
AU2009240510B2 (en) * 2008-04-24 2014-08-21 Medtronic, Inc. Rehydratable polysaccharide particles and sponge
AU2009240513B2 (en) * 2008-04-24 2015-03-26 Medtronic, Inc. Chitosan-containing protective composition
JP2011518837A (ja) 2008-04-24 2011-06-30 メドトロニック，インコーポレイテッド 再水和可能なチオール化多糖粒子およびスポンジ
WO2009132227A1 (fr) * 2008-04-24 2009-10-29 Medtronic, Inc. Gel protecteur à base de chitosane et de polysaccharide oxydé
FR2955258A1 (fr) * 2010-01-20 2011-07-22 Biopharmex Holding Ltd Composition injectable
FR2983070B1 (fr) * 2011-11-30 2014-04-25 Cytosial Biomedic Solution aqueuse homogene de chitosane injectable
US8889655B2 (en) 2012-07-20 2014-11-18 Aegis Women's Health Technologies Compositions and methods for preventing infectious diseases in females
CN102816348B (zh) * 2012-08-01 2015-02-25 宁波大学 一种壳聚糖天冬氨酸琥珀酸复合盐及其作为增鲜剂的应用
CN103349261B (zh) * 2012-08-01 2015-10-07 宁波大学 一种壳聚糖谷氨酸琥珀酸复合盐
CN102838690B (zh) * 2012-08-01 2014-10-08 宁波大学 一种壳聚糖复合盐及其作为增鲜剂的应用
CN105142399B (zh) 2013-03-14 2018-06-12 金珂生物医疗公司 生物相容的和生物可吸收的衍生的壳聚糖组合物

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300494A (en) * 1986-06-06 1994-04-05 Union Carbide Chemicals & Plastics Technology Corporation Delivery systems for quaternary and related compounds
US4803075A (en) 1986-06-25 1989-02-07 Collagen Corporation Injectable implant composition having improved intrudability
US5258028A (en) * 1988-12-12 1993-11-02 Ersek Robert A Textured micro implants
US5143724A (en) * 1990-07-09 1992-09-01 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
DE4200080A1 (de) * 1992-01-03 1993-09-30 Reinmueller Johannes Pharmazeutische Zusammensetzung zur Wund-, Narben- und Keloidbehandlung
US5658593A (en) * 1992-01-16 1997-08-19 Coletica Injectable compositions containing collagen microcapsules
US7060287B1 (en) * 1992-02-11 2006-06-13 Bioform Inc. Tissue augmentation material and method
GB2281861B (en) 1993-09-21 1997-08-20 Johnson & Johnson Medical Bioabsorbable wound implant materials containing microspheres
US6054462A (en) * 1994-04-13 2000-04-25 Janssen Pharmaceutica, N.V. Intranasal antimigraine compositions
US5451406A (en) * 1994-07-14 1995-09-19 Advanced Uroscience, Inc. Tissue injectable composition and method of use
US5599852A (en) 1994-10-18 1997-02-04 Ethicon, Inc. Injectable microdispersions for soft tissue repair and augmentation
US5599916A (en) * 1994-12-22 1997-02-04 Kimberly-Clark Corporation Chitosan salts having improved absorbent properties and process for the preparation thereof
FR2733426B1 (fr) 1995-04-25 1997-07-18 Debacker Yves Dispositif medical pour le comblement des deformations du volume de la peau telles que rides et cicatrices par injection de 2 formes physico-chimiques differentes d'un polymere biologique
FR2736835B1 (fr) * 1995-07-17 1997-10-10 Aber Technologies Pansement pour plaies chroniques, notamment escarres, en gel de chitine
US6060534A (en) * 1996-07-11 2000-05-09 Scimed Life Systems, Inc. Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties
JPH10175847A (ja) * 1996-12-13 1998-06-30 Yasumasa Sawada ハンドソープ組成物
JPH10175857A (ja) * 1996-12-19 1998-06-30 Sekisui Chem Co Ltd 創傷治療剤
FR2758083B1 (fr) * 1997-01-03 1999-02-05 Oreal Composition cosmetique et/ou dermatologique contenant une dispersion d'un systeme polymerique et utilisation de ce systeme comme tenseur
FR2764514B1 (fr) * 1997-06-13 1999-09-03 Biopharmex Holding Sa Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique
CA2212300A1 (fr) * 1997-08-04 1999-02-04 Abdellatif Chenite Gelification in vitro ou in vivo du chitosane et utilisations therapeutiques du chitosane
US6130321A (en) * 1998-07-10 2000-10-10 Vanson, Inc. High tap density chitosan, and methods of production
US6740752B2 (en) * 2000-05-12 2004-05-25 The Procter & Gamble Company Process for preparing chitosan particles
PL340132A1 (en) * 2000-05-12 2001-11-19 Procter & Gamble Method of obtaining modified microcrystalline chitosamine
AU2002220396A1 (en) * 2000-11-15 2002-05-27 Bio Syntech Canada Inc Filler composition for soft tissue augmentation and reconstructive surgery
US20030091851A1 (en) * 2001-10-31 2003-05-15 National University Of Singapore Method of preparing chitin films
CA2467049C (fr) * 2001-11-15 2011-04-12 Abdellatif Chenite Composition et procede permettant de modifier ou de reticuler de facon homogene un chitosane dans des conditions neutres
AU2003230792A1 (en) * 2002-04-03 2003-10-20 Artecel Sciences, Inc. Improvements of adipocytic differentiated adipose derived adult stem cells and uses thereof
KR100523953B1 (ko) * 2002-08-27 2005-10-25 주식회사 엘지생명과학 천연다당류와 히알루론산의 마이크로비드 및 이의 제조 방법
CA2507769C (fr) * 2002-11-27 2013-10-01 Kobo Products, Inc. Suspensions particulaires a densite controlee pour produits alimentaires, cosmetiques, pharmaceutiques et autres utilisations
TW200517128A (en) * 2003-11-17 2005-06-01 China Testile Inst Micro-particles of hydrogel containing polysaccharide or its derivatives composition and method for preparing the same
US20050208095A1 (en) * 2003-11-20 2005-09-22 Angiotech International Ag Polymer compositions and methods for their use
US7901707B2 (en) * 2004-03-15 2011-03-08 Christine Allen Biodegradable biocompatible implant and method of manufacturing same
WO2005105058A1 (fr) 2004-05-04 2005-11-10 Amorepacific Corporation Formulation pouvant etre injectee a liberation soutenue pour le traitement ou la prevention de maladies osseuses comprenant des micro-particules polymeriques qui contiennent du disphosphonate
ITRM20040539A1 (it) * 2004-11-02 2005-02-02 Mavi Sud S R L Preparati a base di chitina o suoi derivati per uso cosmetico o medico.
US20090022770A1 (en) * 2004-12-20 2009-01-22 Mats Andersson Chitosan Compositions
US20060177480A1 (en) * 2005-02-10 2006-08-10 Hsing-Wen Sung Drug-eluting biodegradable stent
US20070077305A1 (en) * 2005-10-03 2007-04-05 Le Tien C Biocompatible polymeric matrix and preparation thereof
GB0526503D0 (en) * 2005-12-29 2006-02-08 Medtrade Products Ltd Hemostatic material
GB0526505D0 (en) * 2005-12-29 2006-02-08 Medtrade Products Ltd Hemostatic material
FR2897775B1 (fr) 2006-02-24 2013-05-03 Elisabeth Laugier Biomateriau, implant injectable le comprenant, son procede de preparation et ses utilisations
US8313762B2 (en) * 2006-07-05 2012-11-20 Medtronic Xomed, Inc. Flexible bioresorbable hemostatic packing and stent
US7776840B2 (en) * 2007-02-21 2010-08-17 Cutanea Life Sciences, Inc. Methods of use of biomaterial and injectable implant containing biomaterial

Also Published As

Publication number Publication date
CA2643783C (fr) 2015-06-16
EP1986599B1 (fr) 2013-11-20
US20070202142A1 (en) 2007-08-30
US9339590B2 (en) 2016-05-17
JP5165596B2 (ja) 2013-03-21
US10086111B2 (en) 2018-10-02
CN101404977B (zh) 2012-09-19
PL1986599T3 (pl) 2014-04-30
BRPI0708157B1 (pt) 2016-05-17
CN101404977A (zh) 2009-04-08
AR059598A1 (es) 2008-04-16
BRPI0708157A2 (pt) 2011-05-17
WO2007096748A3 (fr) 2007-11-22
KR101402832B1 (ko) 2014-06-19
MX2008010718A (es) 2008-12-18
ES2444850T3 (es) 2014-02-27
FR2897775A1 (fr) 2007-08-31
CA2643783A1 (fr) 2007-08-30
JP2009527311A (ja) 2009-07-30
IL193540A0 (en) 2011-08-01
KR20090003262A (ko) 2009-01-09
US20160213816A1 (en) 2016-07-28
RU2008137983A (ru) 2010-03-27
EP1986599A2 (fr) 2008-11-05
WO2007096748A2 (fr) 2007-08-30
IL193540A (en) 2013-11-28

Similar Documents

Publication Publication Date Title
FR2897775B1 (fr) Biomateriau, implant injectable le comprenant, son procede de preparation et ses utilisations
IL238438A0 (en) 2,2,2-trifluoroacetophenones and a method for their preparation
FR2910351B1 (fr) Catalyseur d'hydrotraitement, son procede de preparation et son utilisation.
FR2903992B1 (fr) Composition de scintillateur, article et procede associe.
BRPI0813757A2 (pt) Sistema de implante, e, método
WO2007112446A3 (fr) Nanofibres à base d'alginate et structures d'échafaudage associées
FR2911866B1 (fr) Solide cristalise izm-1 et son procede de preparation.
FR2954773B1 (fr) Polyamide semi-aromatique, son procede de preparation, composition comprenant un tel polyamide et leurs utilisations
EP1963500A4 (fr) Compositions comprenant des macromolecules immobilisees et orientees et leurs procedes de preparation
EP2151500A4 (fr) -glucan ramifié, -glucosyltransférase produisant celui-ci, son procédé de fabrication et son utilisation
BRPI0822633A2 (pt) Desinfetante, e, método de esterilização.
IL192158A0 (en) Cationic oligonucleotides, automated methods for preparing same and their uses
EP2195090A4 (fr) Dispositif implantable, système comportant celui-ci, et procédé utilisant celui-ci
PL2242863T3 (pl) Sposób wytwarzania wyrobów tłoczonych oraz wyroby tłoczone wytworzone tym sposobem
BRPI0817062A2 (pt) Composições emolientes e de poliamida, produtos produzidos e métodos de produção e utilização de tais composições e produtos.
WO2009017231A2 (fr) Système, dispositif, procédé et programme visant à examiner un motif
GB201014466D0 (en) Equivalent material constant calculation system, an equivalent material constant calculation program, equivalent material constant calculation method,
FR2932486B1 (fr) Procede de preparation d'un polyamideimide, polyamideimide et composition comprenant ce polyamideimide.
IL205073A (en) 2 bst antibodies, methods of making them, medicinal preparations containing them and their use
EP2315126A4 (fr) Programme de collecte d'informations parasites, procédé de collecte d'informations parasites, et système de collecte d'informations parasites
HK1121004A1 (en) Sock and method for producing the same
IL184314A0 (en) Substituted 4-phenyltetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them
EP2346899A4 (fr) Anticorps à pénétration cellulaire, spécifique de séquence et hydrolysant les acides nucléiques, son procédé de préparation et composition pharmaceutique le contenant
WO2012050879A3 (fr) Procédés de traitement de microsphères, microsphères ainsi traitées, et utilisations associées
EP2156781A4 (fr) Système endoscopique de type à capsule, et programme et procédé pour le système

Legal Events

Date Code Title Description
CL Concession to grant licences
TP Transmission of property
RM Correction of a material error
TP Transmission of property

Owner name: CUTANEA LIFE SCIENCES, INC., US

Effective date: 20130605

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

TP Transmission of property

Owner name: MARUHO CO., LTD., JP

Effective date: 20191210

ST Notification of lapse

Effective date: 20201006